Proteomics International Laboratories Ltd is pleased to announce that the US Centers for Medicare & Medicaid Services has published its final determination of the national reimbursement price in the.
Proteomics International Laboratories Ltd is pleased to provide an opportunity for shareholders and investors to view a virtual presentation by Managing Director Dr Richard Lipscombe who will present.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to provide an opportunity for shareholders and investors to view a virtual presentation by Managing Director Dr Richard Lipscombe.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of its latest investor presentation for a non-deal roadshow to institutional investors.
Proteomics International Laboratories Ltd is pleased to release a copy of its latest investor presentation for a non-deal roadshow to institutional investors. To view the Presentation, please.